Skeletal Muscle Damage in COVID-19: A Call for Action

Skeletal Muscle Damage in COVID-19: A Call for Action

Both laboratory investigations and body composition quantification measures (e.g., computed tomography, CT) portray muscle loss in symptomatic Coronavirus disease 2019 (COVID-19) patients. Muscle loss is associated with a poor prognosis of the disease. The exact mechanism of muscle damage in COVID-1...

Full description

Bibliographic Details
Main Authors:	Amira Mohammed Ali, Hiroshi Kunugi
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Medicina
Subjects:	coronavirus disease 2019 COVID-19 cytokine storm intensive care unit-acquired weakness older adults aging
Online Access:	https://www.mdpi.com/1648-9144/57/4/372

Similar Items

Approaches to Nutritional Screening in Patients with Coronavirus Disease 2019 (COVID-19)
by: Amira Mohammed Ali, et al.
Published: (2021-03-01)

Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies
by: Amira Mohammed Ali, et al.
Published: (2021-02-01)

Hypoproteinemia predicts disease severity and mortality in COVID-19: a call for action
by: Amira Mohammed Ali, et al.
Published: (2021-04-01)

Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences
by: Jianfen Meng, et al.
Published: (2021-01-01)

The relationship between serum levels of interleukin-2 and IL-8 with circulating microRNA-10b in patients with COVID-19
by: Zahra Bagheri-Hosseinabadi, et al.
Published: (2021-03-01)

Biomarkers in COVID-19: An Up-To-Date Review
by: Madhusudan Samprathi, et al.
Published: (2021-03-01)

Immune Parameters and COVID-19 Infection – Associations With Clinical Severity and Disease Prognosis
by: Milos Jesenak, et al.
Published: (2020-06-01)

MUSCLE WEAKNESS ASSESSMENT IN OLDER INTENSIVE CARE UNIT PATIENTS
by: Amanda Colombo Peteck Lopes, et al.
Published: (2020-10-01)

A 21st Century Evil: Immunopathology and New Therapies of COVID-19
by: Taylon Felipe Silva, et al.
Published: (2020-10-01)

The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
by: Tao Liu, et al.
Published: (2020-07-01)

Complications of coronavirus 2019 (COVID-19): A call for action
by: Soheil Hassanipour, et al.
Published: (2021-06-01)

The Scientific Foundation of Chinese Herbal Medicine against COVID-19
by: Elaine Lai-Han Leung, et al.
Published: (2020-10-01)

Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients
by: Lili Li, et al.
Published: (2021-01-01)

Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19
by: Zhen Qin, et al.
Published: (2021-02-01)

Human Coronaviruses: Counteracting the Damage by Storm
by: Dewald Schoeman, et al.
Published: (2021-07-01)

COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions
by: Babak Arjmand, et al.
Published: (2021-06-01)

Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury
by: Xianyang Chen, et al.
Published: (2020-08-01)

COVID-19: A pandemic that threatens physical and mental health by promoting physical inactivity
by: Amira Mohammed Ali, et al.
Published: (2020-12-01)

Does the Coronavirus (COVID-19) Pandemic Call for a New Model of Older People Care?
by: Leonardo Palombi, et al.
Published: (2020-06-01)

Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations
by: Artur Słomka, et al.
Published: (2020-06-01)

Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19
by: Wei-Xi Shen, et al.
Published: (2021-05-01)

Hyperinflammation in Two Severe Acute Respiratory Syndrome Coronavirus 2-Infected Adolescents Successfully Treated With the Interleukin-1 Inhibitor Anakinra and Glucocorticoids
by: Francesca I. Calò Carducci, et al.
Published: (2020-11-01)

Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
by: Prakash Nagarkatti, et al.
Published: (2020-11-01)

Relationship between chest CT manifestations and immune response in COVID-19 patients
by: Susu He, et al.
Published: (2020-09-01)

Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms
by: Khan MA, et al.
Published: (2021-01-01)

Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
by: Luigi Brunetti, et al.
Published: (2020-09-01)

Subcutaneous tocilizumab treatment in patients with severe COVID-19–related cytokine release syndrome: An observational cohort study
by: Antonio Mastroianni, et al.
Published: (2020-07-01)

HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients
by: Álvaro Tamayo-Velasco, et al.
Published: (2021-05-01)

Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019
by: Chunsheng Zhu, et al.
Published: (2020-08-01)

Can Yin-Chai-Xiao-Du decoction be useful of COVID-19? the mechanism research based on network pharmacology
by: Lu Yang, et al.
Published: (2020-06-01)

Efficacy of belt electrode skeletal muscle electrical stimulation on reducing the rate of muscle volume loss in critically ill patients: A randomized controlled trial
by: Kensuke Nakamura, et al.
Published: (2019-09-01)

The impact of universal face masking and enhanced hand hygiene for COVID-19 disease prevention on the incidence of hospital-acquired infections in a Taiwanese hospital
by: Shih-Hao Lo, et al.
Published: (2021-03-01)

Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide
by: Zhiyu Wang, et al.
Published: (2020-07-01)

Merit of an Ursodeoxycholic Acid Clinical Trial in COVID-19 Patients
by: Subbaya Subramanian, et al.
Published: (2020-06-01)

Triggers, Timescales, and Treatments for Cytokine-Mediated Tissue Damage
by: David A. McBride, et al.
Published: (2020-12-01)

Development of Virtual Surveys for the COVID-19 Wave of the AGELESS Longitudinal Study in Malaysia
by: Aravindhan, K, et al.
Published: (2021)

Development of Virtual Surveys for the COVID-19 Wave of the AGELESS Longitudinal Study in Malaysia
by: Abdul Majeed, A.B, et al.
Published: (2021)

Rich at risk: socio-economic drivers of COVID-19 pandemic spread
by: Sebastiano Gangemi, et al.
Published: (2020-07-01)

Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia
by: Yvon Ruch, et al.
Published: (2020-07-01)

Management of COVID-19 in intensive care units
by: Pervin Hanci
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_vasgmmcrqt3hpjjsgotcfp9uk1